Literature DB >> 9723771

Cytokines: principles and prospects.

A Kelso1.   

Abstract

Cytokines participate in the induction and effector phases of all immune and inflammatory responses. They are therefore obvious tools and targets for strategies designed to promote, inhibit or redirect these responses. However, the complexity of the cytokine network has hindered the widespread clinical application of many cytokines and it has become clear that a deeper understanding of the normal operation of this system in health and disease is needed for the therapeutic potential of cytokines to be fully realized. This review summarizes some of the principles that are now thought to underlie the diverse functions of the interleukins, interferons, colony-stimulating factors and tumour necrosis factors in immune and inflammatory reactions in vivo. Genetic and structural relationships between these cytokines, the regulation of their synthesis, and the structures and functions of their receptors are outlined. Current knowledge of these parameters suggests ways in which multiple positive and negative regulatory mechanisms are integrated to balance cytokine benefits and harm under physiological conditions and offers new prospects for rational exploitation of this system.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9723771     DOI: 10.1046/j.1440-1711.1998.00757.x

Source DB:  PubMed          Journal:  Immunol Cell Biol        ISSN: 0818-9641            Impact factor:   5.126


  39 in total

Review 1.  Gene therapy for urologic cancer.

Authors:  Fernando A Ferrer; Ronald Rodriguez
Journal:  Curr Urol Rep       Date:  2002-02       Impact factor: 3.092

2.  Proinflammatory cytokine gene polymorphisms among Hashimoto's thyroiditis patients.

Authors:  Rong-Hsing Chen; Chwen-Tzuei Chang; Wei-Chi Chen; Chang-Hai Tsai; Fuu-Jen Tsai
Journal:  J Clin Lab Anal       Date:  2006       Impact factor: 2.352

Review 3.  Emerging role for TNF-α in erectile dysfunction.

Authors:  Fernando S Carneiro; Robert Clinton Webb; Rita C Tostes
Journal:  J Sex Med       Date:  2010-12       Impact factor: 3.802

4.  Effects of interleukin-33 on cardiac fibroblast gene expression and activity.

Authors:  Jinyu Zhu; Wayne Carver
Journal:  Cytokine       Date:  2012-03-23       Impact factor: 3.861

5.  Radiation-induced lung toxicity in non-small-cell lung cancer: Understanding the interactions of clinical factors and cytokines with the dose-toxicity relationship.

Authors:  Peter G Hawkins; Philip S Boonstra; Stephen T Hobson; Jason W D Hearn; James A Hayman; Randall K Ten Haken; Martha M Matuszak; Paul Stanton; Gregory P Kalemkerian; Nithya Ramnath; Theodore S Lawrence; Matthew J Schipper; Feng-Ming Spring Kong; Shruti Jolly
Journal:  Radiother Oncol       Date:  2017-09-23       Impact factor: 6.280

6.  Role of heterogeneous cell population on modulation of dendritic cell phenotype and activation of CD8 T cells for use in cell-based immunotherapies.

Authors:  Hannah Frizzell; Jaehyung Park; Natacha Comandante Lou; Kim A Woodrow
Journal:  Cell Immunol       Date:  2016-10-13       Impact factor: 4.868

7.  IL-2 and IL-4 polymorphisms as candidate genes in schizophrenia.

Authors:  Markus J Schwarz; Holger Krönig; Michael Riedel; Sandra Dehning; Anette Douhet; Ilja Spellmann; Manfred Ackenheil; Hans-Jürgen Möller; Norbert Müller
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2005-08-17       Impact factor: 5.270

Review 8.  Leishmaniasis: current status of vaccine development.

Authors:  E Handman
Journal:  Clin Microbiol Rev       Date:  2001-04       Impact factor: 26.132

9.  Cytokine release by ovine macrophages following infection with Chlamydia psittaci.

Authors:  G Entrican; R Wilkie; P McWaters; J Scheerlinck; P R Wood; J Brown
Journal:  Clin Exp Immunol       Date:  1999-08       Impact factor: 4.330

10.  Association between IL-4 -589C>T polymorphism and colorectal cancer risk.

Authors:  Qiang Li; Qian Wang; Xiaoyan Xu; Songtao Ren; Li Wang
Journal:  Tumour Biol       Date:  2013-11-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.